Evidence map›Paper›PMID 30333745›Full record

ArticleFrontiers in pharmacology2018

Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities.

Saba Munawar, Monique J Windley, Edwin G Tse, Matthew H Todd, Adam P Hill, Jamie I Vandenberg, Ishrat Jabeen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Journal of medicinal chemistry · 2023
    Article
  9. Article
  10. Article
  11. Molecular Structure-Based Screening of the Constituents ofCurrent issues in molecular biology · 2022
    Article
  12. Article
  13. Article
  14. Computational toxicology (Amsterdam, Netherlands) · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Saba MunawarResearch Center for Modeling and Simulation, National University of Science and Technology, Islamabad, Pakistan.
Monique J WindleyVictor Chang Cardiac Research Institute, Sydney, NSW, Australia.
Edwin G TseSchool of Chemistry, The University of Sydney, Sydney, NSW, Australia.
Matthew H ToddSchool of Chemistry, The University of Sydney, Sydney, NSW, Australia.
Adam P HillVictor Chang Cardiac Research Institute, Sydney, NSW, Australia.
Jamie I VandenbergVictor Chang Cardiac Research Institute, Sydney, NSW, Australia.
Ishrat JabeenResearch Center for Modeling and Simulation, National University of Science and Technology, Islamabad, Pakistan.
Victor Chang Cardiac Research Institute · AUNational University of Sciences and Technology · PKUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hERG (human ether-a-go-go-related gene) encoded potassium ion (K

Indexed as

GRINDhERG inhibitorslong QT syndrommolecular dockingpatch clamppharmcophoretrosade de pointes

Identifiers

PMID30333745
PMCPMC6176658
OpenAlexW2890733421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.